NCT06962995 Multi-Cancer Detection Observational Cohort Study
| NCT ID | NCT06962995 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-05-07 |
| Primary Completion | 2029-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-05-07 with a primary completion date of 2029-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.
Eligibility Criteria
Inclusion Criteria: * Has Mayo Clinic medical record number * Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider * Able to provide informed consent * ≥ 21 years old * Ability to provide blood sample Exclusion Criteria: * Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. Federal Medical Prison) * Known pregnancy (self-reported) * Currently undergoing active cancer treatment other than adjuvant hormone therapy * Invasive cancer diagnosis within the last 3 years
Contact & Investigator
Jewel Samadder, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06962995 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06962995 currently recruiting?
Yes, NCT06962995 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06962995 trial being conducted?
This trial is being conducted at Scottsdale, United States, Jacksonville, United States, Rochester, United States.
Who is sponsoring the NCT06962995 clinical trial?
NCT06962995 is sponsored by Mayo Clinic. The principal investigator is Jewel Samadder, MD at Mayo Clinic. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.